Company profilePharmaceutical#600 of 1,318 in Pakistan✓ No DRAP alerts

PUNJAB MEDICAL SERVICES

Pharmaceutical company · 19 brands · 11 molecules

19 registered products 19 pharmaceutical brands 11 distinct molecules 0 DRAP alerts

Company overview

19
registered products
19
pharmaceutical brands
11
distinct molecules
0
therapeutic classes
0
DRAP alerts

PUNJAB MEDICAL SERVICES is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 19 product registrations across 11 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Methotrexate3 brands
Cytarabine2 brands
Caspofungin2 brands
Docetaxel2 brands
Iohexol2 brands
Irinotecan2 brands
Gemcitabine2 brands
5-Fluorouracil1 brand
Letrozole1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official19 products · Rs 353.82 – Rs 202,094.93
Median across source: Rs 5,824.5

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for PUNJAB

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.